Nov 3, 2006
By:Kaylynn Chiarello-Ebner
ePT--the Electronic Newsletter of Pharmaceutical Technology
San Antonio, TX (Nov. 1)-The opening session of the ?Pharmaceutical Technologies? track at the 2006 Annual Meeting of the American Association of Pharmaceutical Scientists in San Antonio, Texas was standing room only as R. Christian Moreton, PhD, vice-president of pharmaceutical science at Idenix Pharmaceuticals, and Richard O. Mannion of Purdue Pharma discussed ?Product Development Using a Virtual Company Model.?
 |
Oct 19, 2006
By:Patricia Van Arnum
ePT--the Electronic Newsletter of Pharmaceutical Technology
New York, NY (Oct. 19)-Pfizer, Inc. plans to implement a new company-wide cost-cutting initiative in 2007 as part of strategy to improve operating performance. The cuts are in addition to a previous cost-reduction program that Pfizer launched in 2005.
|
Oct 12, 2006
By:Brianne Harrison
ePT--the Electronic Newsletter of Pharmaceutical Technology
Langley, BC, Canada (Oct. 10)-AnorMED Inc. has determined that Genzyme's US $580 million offer to acquire all outstanding AnorMED shares at US $13.50 a share is a "superior proposal."
|
Sep 21, 2006
By:Brianne Harrison
ePT--the Electronic Newsletter of Pharmaceutical Technology
Kevin Sharer has become chairman of the board of the Pharmaceutical Research and Manufacturers of America upon the resignation of Peter R. Dolan.
|
Sep 21, 2006
By:Patricia Van Arnum
ePT--the Electronic Newsletter of Pharmaceutical Technology
Merck KGaA has agreed to buy a majority stake in the European biotechnology company Serono SA for CHF 16.6 billion ($13.3 billion).
|
Sep 14, 2006
By:Patricia Van Arnum
ePT--the Electronic Newsletter of Pharmaceutical Technology
Chemir Analytical Services has launched IQsynthesis, formerly known as Gateway Chemical Technology, Inc. Chemir acquired Gateway Chemical Technology, which provides custom synthesis and process development services, in May 2006.
|
Jun 14, 2007
By:Brianne Harrison
ePT--the Electronic Newsletter of Pharmaceutical Technology
Cambridge, MA (June 7)-Genzyme Corp. is growing, with a new biomanufacturing plant planned and other expansions nearing completion.
|
May 31, 2007
By:Erik Greb
ePT--the Electronic Newsletter of Pharmaceutical Technology
Cambridge, MA (May 30)-Genzyme agreed to buy its US partner Bioenvision (New York) in an all-cash transaction worth $345 million.
|
May 24, 2007
By:Erik Greb
ePT--the Electronic Newsletter of Pharmaceutical Technology
Mumbai, India (May 21)-Sun Pharmaceutical Industries and its subsidiaries signed definitive agreements to acquire Taro Pharmaceutical Industries, a generics manufacturer with subsidiaries and manufacturing operations in the United States, Canada, and Israel.
|
| 
